XEMYS Trademark

Biological preparations for the treatment of multiple sclerosis; chemical preparations for pharmaceutical or medical purposes, namely, for treatment of multiple sclerosis or prevention of relapses of multiple sclerosis; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; human vaccine preparations; hormones; medical preparations for the treatment of multiple sclerosis; medicaments for delaying of multiple sclerosis progression and reduce of multiple sclerosis relapses; mixed biological preparations for the prevention and treatment of infectious diseases; mixed hormone preparations; molecular complex for the delivery of non-radical oxygen for medicinal, surgical, therapeutic or veterinary purposes; multivitamin preparations; multi-vitamin preparations; nasal and oral spray preparations for use as central nervous system stimulants; nasal spray preparations; nose drops; pain relief medication; pharmaceutical agents affecting peripheral nervous system; pharmaceutical agents affecting sensory organs; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical preparations, namely, antidepressants; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for the prevention of relapses of multiple sclerosis; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations for the treatment and prevention of multiple sclerosis; pharmaceutical preparations for treatment of multiple sclerosis or prevention of relapses of multiple sclerosis; pharmaceutical preparations for peripheral nervous system; pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the treatment of musculo-skeletal disorders; preparation for the relief of pain; reagents for medical use; steroids; synthetic peptides for the treatment of multiple sclerosis; therapeutic pharmaceutical for the treatment of multiple sclerosis; vaccine preparations; vaccines; vitamin and mineral preparations for medical use; vitamins